Stalicla
Stalicla is a Geneva-based company developing a drug development platform for neurodevelopmental disorders.
2
Funding Rounds
$25.0m
Money raised
Overview
Stalicla is a Geneva-based company developing a drug development platform for neurodevelopmental disorders.
- Website:
- Headquarters: Geneva
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Stalicla has raised a total of $24.97m in funding over 2 rounds.
Key Insights:
- Stalicla January 2024 Series B Funding Round: $14m
- Stalicla Series A round, January 2019: $10.97m
Stalicla January 2024 Series B Funding Round
$14m
Stalicla Series A round, January 2019
$10.97m
Industries
Stalicla is active in the following industries: